GENDER DEVELOPMENT IN INTERSEXUAL PATIENTS

描述 这项拟议的研究将检查成年中间性人的性别发展。 病人。将通过使用以下工具评估性别发展 问卷调查和心理访谈。来自这些的信息 调查问卷和访谈将结合以下内容进行分析 间性人的早期雄激素暴露和内分泌治疗结果 病人。最后，中间性患者的父母将接受询问 关于他们做出的关于他们孩子的医疗决定 治疗。参与者将从接受治疗的患者中挑选出来 先天性肾上腺增生症或46，XY假两性畸形 约翰·霍普金斯医院儿科内分泌临床(1943-1998) 这组双性患者是已确定的最大群体之一 在美国可用，其中许多人已经 在米根博士之前进行的调查中被找到。这 研究将扩大我们对性别发展的理解 在控制病因和治疗(两者)的同时，中间性患者 内分泌和外科)，并可提供有关 目前关于适当的治疗指南的争议 双性恋的孩子。

DESCRIPTION The proposed research will examine gender development in adult intersexual patients. Gender development will be assessed through the use of questionnaires and psychological interviews. Information from these questionnaires and interviews will be analyzed in concert with extent of early androgen exposure, endocrine treatment outcome of the intersexual patients. Lastly, parents of intersexual patients will be questioned concerning the medical decisions they made relating to their child's treatment. Participants will be selected from patients treated for congenital adrenal hyperplasia (CAH) or 46,XY pseudohermaphroditism in the Pediatric Endocrine Clinical at John Hopkins Hospital from 1943 to 1998. This group of intersex patients is one of the largest identified groups available in the United States, and many of these individuals have already been located for previous investigation conducted by Dr. Migeon. This research will broaden our understanding of gender development among intersexual patients while controlling for etiology and treatment (both endocrine and surgical), and may provide useful information regarding the current dispute over appropriate guidelines for medical treatment of intersexual children.